A. Rees

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Anthony R Rees, A. R. Rees, A Rees, A R Rees, Anthony R. Rees, A.r. Rees, Anthony Rees, Anthony Robert Rees
Publication record
141 papers · 4,244 citations · H-index 35

PAPERS

Diphtheria and tetanus: the discovery of passive immunization
20220 citationsauthor #1
Filoviruses: modern solutions to life-threatening infections
20220 citationsauthor #1
Vaccination and freedom of choice: the individual and the population
20220 citationsauthor #1
The biological origins of infection unveiled
20220 citationsauthor #1
The tuberculosis roller coaster: vaccines and antibiotics
20220 citationsauthor #1
The scourge of smallpox: variolation, vaccination, and Edward Jenner
20221 citationsauthor #1
Influenza virus: an evolving chameleon
20220 citationsauthor #1
Viruses: epic challenges for vaccinology
20220 citationsauthor #1
Smallpox vaccination in the 19th century: obstinacy versus pragmatism
20220 citationsauthor #1
Some tropical diseases: the flaviviruses
20220 citationsauthor #1
Infectious diseases: a historical documentary
20220 citationsauthor #1
Measles, mumps, and rubella: vaccination, mortality, and uncertainty
20220 citationsauthor #1
Viruses, vaccines and cardiovascular effects.
20221 citationsauthor #1
The Polio virus: its conquest amid inflamed debate and controversy
20222 citationsauthor #1
Cholera, plague, typhoid, and paratyphoid: a cautious start to a vaccine revolution
20221 citationsauthor #1
Vaccines are not always perfect: adverse effects and their clinical impact
20220 citationsauthor #1
Current strategies for detecting functional convergence across B-cell receptor repertoires
202127 citationsauthor #2
Antibodies: A History of Their Discovery and Properties
20200 citationsauthor #1
Understanding the human antibody repertoire
202086 citationsauthor #1
A 11 Patent Number : 5 , 639 , 641 45 Date of Patent : Jun . 17 , 1997
20170 citationsauthor #3
[S]pinning Balaam against the wall
20170 citationsauthor #1
Extracting human antibody sequences from public databases for antibody humanization: high frequency of species assignment errors.
20166 citationsauthor #2
Immunoglobulin constant regions
20140 citationsauthor #1
The cellular reformation
20140 citationsauthor #1
The foundations of antibody-antigen recognition emerge
20140 citationsauthor #1
Effector functions of constant regions
20140 citationsauthor #1
The structural context of antibody diversity
20140 citationsauthor #1
Pre-molecular immunology
20140 citationsauthor #1
Transmission and catabolism of IgG
20140 citationsauthor #1
Uncovering the origins of antibody diversity
20140 citationsauthor #1
Monoclonal antibodies and the mechanisms of hypermutation
20140 citationsauthor #1
Antibody structure prediction and development of humanization strategies
20141 citationsauthor #1
Therapeutic antibodies Case study II
20140 citationsauthor #1
Antibody pre-history
20140 citationsauthor #1
The molecular path unfolds
20140 citationsauthor #1
The Antibody Molecule: From antitoxins to therapeutic antibodies
201413 citationsauthor #1
Affinity material for antibody purification
20100 citationsauthor #1
Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering.
200887 citationsauthor #3
Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy
200528 citationsauthor #7
Antibody Variable Regions
200420 citationsauthor #2
2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance
20049 citationsauthor #5
Antibody variable regions: toward a unified modeling method.
200415 citationsauthor #2
Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy
200386 citationsauthor #7
Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides*
2003494 citationsauthor #4
Composes et compositions pour le transport de la cyclosporine a travers la barriere hemato-encephalique
20030 citationsauthor #2
VectorsUsing Antigens Conjugated to Short Peptide Induction of Antigen-Specific CTL Responses
20030 citationsauthor #5
A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.
200342 citationsauthor #13
Induction of Antigen-Specific CTL Responses Using Antigens Conjugated to Short Peptide Vectors
200310 citationsauthor #6
Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors
200251 citationsauthor #4
Composes, compositions et methode pour le transport des molecules de cyclosporine a travers la barriere hemato-encephalique
20020 citationsauthor #2
Compounds containing a bound to a vector molecule analgesic
20020 citationsauthor #2
Compositions consisting of a analgesic molecule associated with a vector.
20020 citationsauthor #2
Compounds, compositions and method for the transport of cyclosporin molecules across the blood-brain barrier
20020 citationsauthor #2
A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics
200245 citationsauthor #8
Reduced antibody response to streptavidin through site‐directed mutagenesis
200175 citationsauthor #8
Vector-mediated drug delivery to the brain
200139 citationsauthor #3
Compounds consisting of an analgesic molecule linked to a vector capable of vectorizing said molecule through the blood-brain barrier and pharmaceutical compositions containing them
20010 citationsauthor #2
The hunchback and its neighbours: proline as an environmental modulator.
2001117 citationsauthor #2
Sodium sulphate reactivates a protein A minidomain with a short elastin beta-turn.
20004 citationsauthor #2
Trifluoroethanol may form a solvent matrix for assisted hydrophobic interactions between peptide side chains.
2000115 citationsauthor #2
Sodium Sulphate Reactivates a Protein A Minidomain with a Short Elastin β-Turn
200012 citationsauthor #2
Tumour Targetting Human Antibodies specific to the Pan-Carcinoma Antigen Epithelial Glycoprotein-2 by Guided Selection of a Murine Antibody
20000 citationsauthor #6
WAM: an improved algorithm for modelling antibodies on the WEB.
2000161 citationsauthor #2
Linear amphipathic peptides and compositions containing
20000 citationsauthor #4
Mutating ADEPT enzyme CPG2 to reduce its immunogenicity
20003 citationsauthor #5
Calculation methods for the production of molecular mimetics
20000 citationsauthor #5
Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation.
200022 citationsauthor #5
Molecular Modeling and Preclinical Evaluation of the Humanized NR-LU-13 Antibody 1
19990 citationsauthor #10
An engineered minidomain containing an elastin turn exhibits a reversible temperature-induced IgG binding.
199923 citationsauthor #2
Identifying immunogenic sites on adept enzymes CPG2 using a SCFV phage library & SELDI (TM)-AMS.
19991 citationsauthor #7
Short elastin-like peptides exhibit the same temperature-induced structural transitions as elastin polymers: implications for protein engineering.
1998185 citationsauthor #3
Inhibition of Activating Transcription Factor 1- and cAMP-responsive Element-binding Protein-activated Transcription by an Intracellular Single Chain Fv Fragment*
199819 citationsauthor #5
Anticorps humanises a glycosylation modifiee
19970 citationsauthor #8
Molecular modeling of antibody-combining sites.
199543 citationsauthor #2
Preparation of N-9-Fluorenylmethyloxycarbonyl-Asparagine-Pentafluorophenyl Ester from the Free Acid
19950 citationsauthor #3
Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide
199540 citationsauthor #3
Antibody-antigen interactions
1994206 citationsauthor #3
Antibody-combining sites
19947 citationsauthor #5
Antibody design: beyond the natural limits.
199442 citationsauthor #1
Humanization of murine monoclonal antibodies through variable domain resurfacing.
1994228 citationsauthor #9
Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies.
199461 citationsauthor #6
Molecular cloning of a proteolytic antibody light chain.
199470 citationsauthor #5
Reshaping surface rodent antibodies.
19930 citationsauthor #3
Surface Conversion of rodent antibodies
19930 citationsauthor #3
Surface transformation of rodent antibodies
19930 citationsauthor #3
Surface forming of antibodies rodenten
19930 citationsauthor #3
Antibody modeling: Beyond homology
199220 citationsauthor #4
Protein engineering : a practical approach
199266 citationsauthor #1
Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen.
1992204 citationsauthor #6
Mechanistic studies of a tyrosine-dependent catalytic antibody.
199127 citationsauthor #4
Characterization of the mechanism of action of a catalytic antibody.
19910 citationsauthor #4
New applications for antibodies
19900 citationsauthor #3
Procedes d'amelioration de la vitesse de modification de liaisons metastables
19900 citationsauthor #2
A monoclonal antibody which recognises a receptor for interleukin 2 on pig lymphocytes
19901 citationsauthor #3
Production of a recombinant immunoglobulin variable fragment from polypeptides expressed in the cytoplasm of Escherichia coli
19900 citationsauthor #2
Potentiometric biosensor employing catalytic antibodies as the molecular recognition element.
199047 citationsauthor #7
Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity.
199039 citationsauthor #3
Methods for increasing the rate of modification of the metastable bond
19900 citationsauthor #3
Antibody-combining sites: prediction and design.
19901 citationsauthor #6
Healing process using a catalytic antibody
19890 citationsauthor #2

TIMELINE

1939 52 citations

1972 11 citations

1976 24 citations

1979 126 citations

1980 79 citations

1981 168 citations

1983 16 citations

1984 235 citations

1985 436 citations

1986 146 citations

1987 34 citations

1988 2 citations

1989 11 citations

1990 88 citations

1991 27 citations

1992 290 citations

1993 0 citations

1994 614 citations

1995 83 citations

1997 0 citations

1998 204 citations

1999 24 citations

2000 317 citations

2001 231 citations

2002 96 citations

2003 632 citations

2004 44 citations

2005 28 citations

2008 87 citations

2010 0 citations

2014 14 citations

2016 6 citations

2017 0 citations

2020 86 citations

2021 27 citations

2022 5 citations

Unknown 2 citations

A. Rees

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT